ATE203906T1 - Zubereitung zur perkutanen verabreichung enthaltend 6-amino-5-chloro-1-isopropyl-2-(4- methyl-1-piperazinyl)benzimidazol - Google Patents

Zubereitung zur perkutanen verabreichung enthaltend 6-amino-5-chloro-1-isopropyl-2-(4- methyl-1-piperazinyl)benzimidazol

Info

Publication number
ATE203906T1
ATE203906T1 AT97922189T AT97922189T ATE203906T1 AT E203906 T1 ATE203906 T1 AT E203906T1 AT 97922189 T AT97922189 T AT 97922189T AT 97922189 T AT97922189 T AT 97922189T AT E203906 T1 ATE203906 T1 AT E203906T1
Authority
AT
Austria
Prior art keywords
preparation
benzimidazole
piperazinyl
chloro
isopropyl
Prior art date
Application number
AT97922189T
Other languages
English (en)
Inventor
Takateru Muraoka
Keigo Inosaka
Hitoshi Akemi
Hiroko Ishitani
Saburo Otsuka
Yoshiteru Takahashi
Original Assignee
Nitto Denko Corp
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nitto Denko Corp, Akzo Nobel Nv filed Critical Nitto Denko Corp
Application granted granted Critical
Publication of ATE203906T1 publication Critical patent/ATE203906T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT97922189T 1996-05-29 1997-05-26 Zubereitung zur perkutanen verabreichung enthaltend 6-amino-5-chloro-1-isopropyl-2-(4- methyl-1-piperazinyl)benzimidazol ATE203906T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8134914A JPH09315976A (ja) 1996-05-29 1996-05-29 経皮投与用製剤
PCT/JP1997/001781 WO1997045121A1 (fr) 1996-05-29 1997-05-26 Preparation destinee a une administration percutanee

Publications (1)

Publication Number Publication Date
ATE203906T1 true ATE203906T1 (de) 2001-08-15

Family

ID=15139492

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97922189T ATE203906T1 (de) 1996-05-29 1997-05-26 Zubereitung zur perkutanen verabreichung enthaltend 6-amino-5-chloro-1-isopropyl-2-(4- methyl-1-piperazinyl)benzimidazol

Country Status (7)

Country Link
US (1) US6077528A (de)
EP (1) EP0965342B1 (de)
JP (1) JPH09315976A (de)
CN (1) CN1219874A (de)
AT (1) ATE203906T1 (de)
DE (1) DE69706070T2 (de)
WO (1) WO1997045121A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10167956A (ja) * 1996-12-11 1998-06-23 Hisamitsu Pharmaceut Co Inc セロトニン受容体拮抗薬含有経皮投与製剤
US6132761A (en) * 1997-09-05 2000-10-17 Nitto Denko Corporation Percutaneous absorption preparation
JP5334346B2 (ja) * 1999-08-10 2013-11-06 久光製薬株式会社 ロール状外用貼付剤
JP5021124B2 (ja) 2001-08-29 2012-09-05 日東電工株式会社 医療用粘着組成物、それを用いた医療用粘着テープおよび経皮吸収用テープ製剤
JP4311728B2 (ja) * 2003-12-10 2009-08-12 ニチバン株式会社 経皮吸収型貼付剤
CA2548864C (en) * 2005-06-06 2012-12-11 Nitto Denko Corporation Percutaneous absorption-type pharmaceutical preparation
EP1731143B1 (de) * 2005-06-06 2008-11-26 Nitto Denko Corporation Pharmazeutische Zusammensetzung zur perkutane Absorption unter Verwendung von einem Metalchlorid, vorzugsweise Natriumchlorid, zur Vorbeugung von Kohäsionsschwäche
JP2008101027A (ja) * 2008-01-17 2008-05-01 Nitto Denko Corp 経皮吸収型製剤
JP2012031071A (ja) * 2010-07-28 2012-02-16 Nitto Denko Corp 貼付剤および貼付製剤
EP2551102B1 (de) * 2011-07-29 2014-12-03 3M Innovative Properties Company Selbstklebendes Schaumhaftmittel
JP7282701B2 (ja) * 2020-01-23 2023-05-29 久光製薬株式会社 パップ剤
CN113423394A (zh) 2019-02-14 2021-09-21 久光制药株式会社 泥罨剂
WO2020172418A1 (en) * 2019-02-22 2020-08-27 Elkem Silicones USA Corp. Drug delivery silicone compositon to improve active ingredient elution

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55131075A (en) * 1979-03-31 1980-10-11 Nitto Electric Ind Co Ltd Adhesive tape
TW201744B (de) * 1991-07-02 1993-03-11 Kanebou Textile Co Ltd
JPH0748258A (ja) * 1993-06-03 1995-02-21 Kanebo Ltd 経皮投与用製剤

Also Published As

Publication number Publication date
US6077528A (en) 2000-06-20
EP0965342B1 (de) 2001-08-08
JPH09315976A (ja) 1997-12-09
CN1219874A (zh) 1999-06-16
DE69706070D1 (de) 2001-09-13
EP0965342A1 (de) 1999-12-22
DE69706070T2 (de) 2002-05-02
EP0965342A4 (de) 2000-02-09
WO1997045121A1 (fr) 1997-12-04

Similar Documents

Publication Publication Date Title
DE69706070D1 (de) Zubereitung zur perkutanen verabreichung enthaltend 6-amino-5-chloro-1-isopropyl-2-(4-methyl-1-piperazinyl)benzimidazol
PT783341E (pt) Dispositivo transdermal melhorado tendo deslaminagem diminuida
DE69942921D1 (de) Osmotische Dosierungsform mit verlängerter Wirkstoffabgabe
WO2001003917A3 (de) Wirkstoffhaltigen mehrschichtfilm aus in situ vernetzten hydrophilen polymeren
DK0922453T3 (da) Tulobuterolholdigt præparat til perkutan absorption
CA2282513A1 (en) Stabilization of acid sensitive benzimidazoles with amino acid/cyclodextrin combinations
FI963916L (fi) Uudet stabiloidut galeeniset formulaatiot, jotka sisältävät happolabiilia bentsimidatsoliyhdistettä, ja niiden valmistus
FI954990L (fi) Aktiiviainetta sisältävä transdermaalinen valmiste
FI953533L (fi) Transdermaalinen terapeuttinen järjestelmä, jossa on galantamiinia vaikuttavana aineena
EP1334731A4 (de) Mittel zur prävention oder behandlung von psoriasis mit einem il-6-antagonist als wirkstoff
EE200000595A (et) Toimeaine viimine kandjamaatriksisse
EP0387751A3 (de) Arzneimittel enthaltendes Heftpflaster
DE69918074D1 (de) Makrolid-formulierung mit verzögerter wirkstoffabgabe
EE04219B1 (et) Säilituskindel toimeainekontsentraat formoterooliga
ATE87481T1 (de) Orale arzneimittelformen von pimobendan.
FI961282A7 (fi) Transdermaalinen terapeuttinen systeemi, jossa on asetyylisalisyylihap po vaikuttavana aineena
DE69923348D1 (de) Transdermales arzneistoffverabreichungssystem
CA2372710A1 (en) Laminates containing an active substance for transdermal systems
CA2339836A1 (en) Active ingredient support in the form of a film
AU6440600A (en) Combination of active agents, said combination containing clonidine
NO954506L (no) Topiske påhelningsformuleringer inneholdende polymert materiale, glycoler og glycerider
DK1142573T3 (da) Farmaceutiske præparater omfattende faropenem-natrium og en diaminacetatforbindelse til forbedring af absorption i mave-tarm-kanalen
AU3078000A (en) Heterocyclic compounds and antitumor agents containing the same as the active ingredient
FI945313L (fi) Parannetun biokäytettävyyden omaavat tabletit, jotka sisältävät dikloorimetyleenifosfonihappoa vaikuttavana aineena
PT1152751E (pt) Sistema terapeutico transdermal de desoxipeganina

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties